Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
A recent paper by Evan Yu, Professor at the University of Washington, was mentioned by Jame Abraham, Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic, on X:
“Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline, Journal of Clinical Oncology”
“Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline”
Authors: Evan Yu, Bryan Rumble, Neeraj Agarwal, Heather Cheng, Scott Eggener, Rhonda Bitting, Himisha Beltran, Veda Giri, Daniel Spratt, Brandon Mahal, Kevin Lu, Tony Crispino, Edouard Trabulsi.
More posts featuring Jame Abraham.
Jame Abraham, MD, FACP, is Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic and a Professor of Medicine at Cleveland Clinic Lerner College of Medicine. He also is a Deputy Editor at the ASCO Post and Journal of Oncology Practice of ASCO.
Dr. Abraham is a member of the National Comprehensive Cancer Network (NCCN) Breast Cancer Committee and holds leadership roles in NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023